Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma

NCT00352833 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Gastric Adenocarcinoma

Interventions

DRUG: catumaxomab

Sponsor

Neovii Biotech